Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

Research output: Contribution to journalArticle

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{bc5bed01d35a462b8142325656248b3a,
title = "Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment",
author = "Christopher Hyde and Beverley Wake and Stirling Bryan and Pelham Barton and Anne Fry-Smith and Clare Davenport and Fujian Song",
year = "2002",
month = jan
day = "1",
language = "English",
volume = "6",
pages = "1--89",
journal = "Health Technology Assessment",
issn = "1366-5278",
publisher = "NIHR Health Technology Assessment Programme",
number = "2",

}

RIS

TY - JOUR

T1 - Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

AU - Hyde, Christopher

AU - Wake, Beverley

AU - Bryan, Stirling

AU - Barton, Pelham

AU - Fry-Smith, Anne

AU - Davenport, Clare

AU - Song, Fujian

PY - 2002/1/1

Y1 - 2002/1/1

M3 - Article

C2 - 12022937

VL - 6

SP - 1

EP - 89

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 2

ER -